Anti-hyperglycemic, lipid-lowering, and anti-obesity effects of the triterpenes α and β-amyrenones in vivo

Document Type : Original Research Article


1 Superior Normal School, Amazonas State University, Djalma Batista 2470, Chapada, 69050-010, Manaus, Manaus, AM, Brazil

2 Faculty of Pharmaceutical Sciences, Federal University of Amazonas, General Rodrigo Otávio 6200, Coroado 1, 69080-900, Manaus, AM, Brazil

3 Institute of Biological Sciences, Federal University of Amazonas, General Rodrigo Otávio 6200, Coroado 1, 69080-900, Manaus, AM, Brazil

4 Department of Chemistry, Military Institute of Engineering, Praça General Tibúrcio 80, Urca, 22290-270, Rio de Janeiro, RJ, Brazil


Objective: Diabetes, obesity, and their associated metabolic disorders are public health problems that require prevention and new efficient drugs for treatment. We evaluated the anti-hyperglycemic, lipid-lowering, and anti-obesity effects of semisynthetic α, β-amyrenones (ABA).
Materials and Methods: BALB/c mice were used for performing an acute model of oral carbohydrate and triglyceride tolerance, and in a streptozotocin-induced diabetes model, where glycemia and body weight changes were measured during ten days. C57BL/6 strain mice were used in the diet-induced obesity model, where lipidemia and body weight were measured during four weeks, and biochemical and histological parameters were analyzed after euthanasia. The doses considered in this study were 25, 50, and 100 mg/kg of ABA, used following some criteria for each experiment.  Results: ABA 25 mg/kg reduced the postprandial glycemia peak higher than acarbose 50 mg/kg (p <0.05). ABA 50 mg/kg significantly reduced glycemia in diabetic mice compared to acarbose 50 mg/kg (p <0.05). There was a reduction in the weight of the obese animals treated with ABA 25 and 50 mg/kg (p <0.05). ABA 50 mg/kg also significantly reduced lipidemia in these animals compared to orlistat 50 mg/kg.
Conclusion: This study presents evidence of ABA's action in reducing postprandial glycemia and obesity in mice.


Adisakwattana S. 2010. Lipid-lowering
mechanisms of grape seed extract (Vitis
vinifera L) and its antihyperlipidemic
activity. J Med Plant Res, 4: 2113-2020.
Almeida PD, Boleti AP, Rudiger AL, Lourenco
GA, Veiga-Junior VF, Lima ES. 2015.
Anti-inflammatory activity of triterpenes
isolated from Protium paniculatum oilresins. Evid Based Complement Alternat
Med, 2015: 293768.
American Diabetes Association (ADA). 2015.
Standards of medical care in Diabetes -
2015: Summary of revisions. Diabetes
Care, 38: Suppl, S4.
Brazilian National Health Surveillance Agency
(ANVISA). 2004. Guia para realização de
estudos de toxicidade pré-clínica de
fitoterápicos. Brasília, Agência Nacional de
Vigilância Sanitária.
Brazilian National Health Surveillance Agency
(ANVISA). 2010. Guia para a condução de
estudos não clínicos de segurança
necessários ao desenvolvimento de
medicamentos. Brasília, Agência Nacional
de Vigilância Sanitária.
Carvalho KM, Marinho-Filho JD, Melo TS,
Araujo AJ, Quetz JS, Cunha MP, Melo
KM, Silva AA, Tome AR, Havt A, Fonseca
SG, Brito GA, Chaves MH, Rao VS, Santos
FA. 2015. The resin from Protium
heptaphyllum prevents high-fat dietinduced obesity in mice: Scientific
evidence and potential mechanisms. Evid
Based Complement Alternat Med,
Carvalho KM, Melo TS, Melo KM, Quinderé
AL, Oliveira FT, Viana AF, Nunes PI,
Quetz JD, Viana DA, Silva AA, Havt A,
Fonseca SG, Chaves MH, Rao VS, Santos
FA. 2017. Amyrins from Protium
heptaphyllum reduce high-fat diet-induced
obesity in mice via modulation of
enzymatic, hormonal, and inflammatory
responses. Planta Med, 83: 285-291.
Gupta M, Sharma P, Nath AK. 2014.
Purification of a novel alpha-amylase
inhibitor from local Himalayan bean
(Phaseolus vulgaris) seeds with activity
towards bruchid pests and human salivary
amylase. J Food Sci Technol, 51: 1286-
International Diabetes Federation (IDF). 2013.
Update of mortality attributable to diabetes
for the IDF diabetes atlas: Estimates for the
year 2011. Diabetes Res Clin Pract, 100:
Queiroz MS, Janebro DI, Cunha MA, Medeiros
JS, Sabaa-Srur AU, Diniz MF, Santos, SC.
2012. Effect of the yellow passion fruit peel
flour (Passiflora edulis f. flavicarpa deg.)
in insulin sensitivity in type 2 diabetes
mellitus patients. Nutr J, 11: 89.
Melo CM, Morais TC, Tome AR, Brito GA,
Chaves MH, Rao VS, Santos FA. 2011.
Anti-inflammatory effect of alpha, betaamyrin, a triterpene from Protium
heptaphyllu, on cerulein-induced acute
pancreatitis in mice. Inflamm Res, 60: 673-
Nazaruk, J, Borzym-Kluczyk M. 2014. The role
of triterpenes in the management of
Diabetes mellitus and its complications.
Effects of α and β-amyrenones on carbohydrates and lipids metabolism
AJP, Vol. 11, No. 5, Sep-Oct 2021 463
Phytochem Rev, 14: 675-690.
Nakamura A, Terauchi Y. 2013. Lessons from
mouse models of high-fat diet-induced
NAFLD. Int J Mol Sci, 14: 21240-21257.
Okoye NN, Ajaghaku D, Okeke HN, Ilodigwe
EE, Nworu CS, Okoye FB. 2014. Betaamyrin and alpha-amyrin acetate isolated
from the stem bark of Alstonia boonei
display profound anti-inflammatory
activity. Pharm Biol, 52: 1478-1486.
Ramirez-Espinosa JJ, Rios MY, LopezMartinez S, Lopez-Vallejo F, MedinaFranco JL, Paoli P, Camici G, NavarreteVazquez G, Ortiz-Andrade R, Estrada-Soto
S. 2011. Antidiabetic activity of some
pentacyclic acid triterpenoids, role of ptp1b: In vitro, in silico, and in vivo
approaches. Eur J Med Chem, 46: 2243-
Santos FA, Frota JT, Arruda BR, Melo TS,
Silva AA, Brito GA, Chaves MH, Rao VS.
2012. Antihyperglycemic and
hypolipidemic effects of alpha, betaamyrin, a triterpenoid mixture from
Protium heptaphyllum in mice. Lipids
Health Dis, 11: 98.
Sharma K, McCue P, Dunn SR. Diabetic kidney
disease in the db/db mouse. 2003. Am J
Physiol Renal Physiol, 284: F1138-1144.
Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS,
Park YM, Lee WC, Kang MI, Yim HW,
Yoon KH, Son HY. 2013. Metabolic
syndrome as a predictor of type 2 diabetes,
and its clinical interpretations and
usefulness. J Diabetes Investig, 4: 334-343.